Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Phase 3 results reported for novel glaucoma eye drop
➤ Update: preventative therapy for patients at risk for radiation retinopathy
➤ Topical drop for diabetic retinopathy does not meet endpoints in Phase 2 trial
➤ ASCRS news and events
Two physicians provided their thoughts on diagnosis of normal tension glaucoma, establishing true progression, and how to manage worsening disease in this patient population
Glaucoma surgeons recently faced a potentially disastrous reimbursement situation when five Medicare Administrative Contractors proposed and finalized limiting coverage of several MIGS procedures. Because of extensive advocacy efforts, it was announced that there would be no change in the coverage at this time.
➤ Enrollment complete in Phase 2 study for drug targeting endocannabinoid system for IOP lowering
➤ Dosing complete for Phase 1/2 trial evaluating a gene therapy for Stargardt disease
➤ Pre-Phase 3 Type B meeting held with FDA by company focused on retinitis pigmentosa
➤ Updates from several late-stage clinical trials
➤ New company launches to pioneer nonviral gene therapies
➤ ASCRS news and events
➤ Study: artificial intelligence matches/outperforms ophthalmologists
➤ Primary endpoint met in Phase 3 trial using an antibody to treat thyroid eye disease
➤ FDA grants Breakthrough Device Designation to novel spectacle design
➤ ASCRS news and events
iCare HOME2 measuring IOP
Source: Thomas Johnson III, MD, PhD
Glaucoma specialists have now had the opportunity to come into the 21st century alongside some of the physicians in other medical specialties who have long used home monitoring devices to collect information on their patients’ conditions to better inform treatment.
➤ ASCRS advocacy helps protect MIGS coverage
➤ FDA approves generic loteprednol etabonate ophthalmic suspension
➤ Orphan Drug Designation granted for corneal endothelial cell substitute
➤ Positive results in Phase 2 clinical trial for contact lens discomfort
➤ First patient visits
➤ Acquisition news
➤ Complimentary access to video journal
➤ ASCRS news and events
Learning a variety of surgery techniques and clinical management approaches is important for surgeons in training. Physicians shared some of their personal experiences, including what they learned in training and since their training ending, and how these experiences have influenced them.
“As the year comes to a close, and before we start worrying about resolutions for the next one, we can all benefit by reflecting on where we are now in order to derive some lessons to carry forward,” said Glaucoma Editor Manjool Shah, MD, in his introduction to the section.
The pros of comanaging glaucoma patients with optometrists and keys to success are covered in this article.